Eliem Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Eliem Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Eliem Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -1.81 USD/shares, a 853% decline year-over-year.
  • Eliem Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -2.14 USD/shares, a 13.8% decline year-over-year.
  • Eliem Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.3 USD/shares, a 24.4% increase from 2022.
  • Eliem Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.72 USD/shares, a 59.4% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2 -$2 -$2 -853% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$1 $0 +$0.78 +92.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$1 $0 +$0.36 +75% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$2 $0 +$0.22 +59.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$2 $0 +$0.18 +48.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2 -$1 $0 -68% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$2 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $0 +$0.33 +47.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $0 +$2.74 +88.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 $1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.